Forms

Click here to download a form.

Insurance

We accept most major insurance plans.
Click here for details.

Photo Gallery

Photo Gallery

Click here to see our clinic!

RSS News

GastroIntestinal / Gastroenterology News From Medical News Today

You are viewing a feed that contains frequently updated content. When you subscribe to a feed, it is added to the Common Feed List. Updated information from the feed is automatically downloaded to your computer and can be viewed in Internet Explorer and other programs. Learn more about feeds.

Subscribe to this feed

What Is Chronic Pancreatitis? What Causes Chronic Pancreatitis?

Yesterday, August 12, 2009, 2:30:00 PM
Chronic pancreatitis is long-term progressive inflammatory disease of the pancreas that leads to permanent deterioration of the structure and function of the pancreas. It is estimated that in Western Europe and North American chronic pancreatitis is diagnosed in 3 to 9 people in every 100,000 each year. The most common cause is long-term alcohol abuse - it is thought to account for approximately 70% of all cases.

Improved Colorectal Cancer Survival Linked To Postdiagnosis Use Of Aspirin

Yesterday, August 12, 2009, 2:30:00 PM
US researchers found that patients who regularly took aspirin after being diagnosed with colorectal cancer had a reduced risk of dying from the disease, and the benefit was greater for patients with a type of colon cancer where the tumors overexpress the COX-2 enzyme, which happens in around two thirds of cases. However, more work needs to be done to confirm the result before applying it to patient care, said the researchers.

Budesonide Is Not Beneficial For The Treatment Of Diarrhea In Metastatic Melanoma Patients

Yesterday, August 12, 2009, 1:30:00 PM
Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research. These findings would "discourage the prophylactic use of budesonide to reduce the gastrointestinal side effects of ipilimumab," said researcher Jeffrey Weber, M.D.

Kenilworth Primary Care. 66 South 21st Street, Kenilworth, NJ 07033
Phone: (908) 276-9595 Fax: (908) 276-6807. Email: drjeereddy@gmail.com

Copyright © 2013 Kenilworth Primary Care. All Rights Reserved.

Disclaimer

Health Care Web Design
by RiaEnjolie

Health Care Web Design